Fort Washington Investment Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-299,803
Closed -$17.4M 417
2024
Q3
$17.4M Sell
299,803
-200,560
-40% -$9.85M 0.11% 181
2024
Q2
$20.3M Buy
500,363
+39,268
+9% +$1.56M 0.13% 140
2024
Q1
$19.4M Buy
461,095
+284,935
+162% +$11.1M 0.12% 160
2023
Q4
$6.75M Buy
+176,160
New +$5.87M 0.05% 207

Other funds holding ASTH

Fort Washington Investment Advisors's ASTH Position: Q4 2024 in Review

Fort Washington Investment Advisors sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 299,803 shares — an estimated $17.4M sold.

Fort Washington Investment Advisors first reported a position in ASTH in Q4 2023 and held it in 4 quarters. The position peaked at $20.3M in Q2 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Fort Washington Investment Advisors reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 299,803 Astrana Health shares in Q4 2024, an estimated $17.4M.
  • Fort Washington Investment Advisors first reported a position in Astrana Health in Q4 2023 and held it in 4 quarters.
  • Fort Washington Investment Advisors's Astrana Health position peaked at $20.3M in Q2 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2024, filed 17 Jan 2025.